Correction to: Acta Pharmacologica Sinica (2022) 44:332–344 https://doi.org/10.1038/s41401-022-00956-w, published online 10 August 2022
The authors would like to apologize for the errors in the previously published images of Fig. 2a. The HE staining in control group presented incorrect accidentally. The inaccuracy was due to an oversight during the preparation of the figures. The authors have carefully checked the raw data and corrected the accidentally confused image. The legend for Fig.1d contains an error regarding the number of mice. It should be changed into“E peak velocity was quantified. n = 7–9.” There is a minor error in the chemical formula of the third compound in Table 1. It should be changed into“C20H21NO4.”
The corrected versions of the affected figures are now presented. It is important to note that these corrections do not alter the findings or conclusions of the paper. The overall interpretation and impact of the study remain unchanged. The authors sincerely apologize for any inconvenience caused to the journal and its readers.
The original article has been corrected.
Revised fig. 2

Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wang, L., Tang, Xq., Shi, Y. et al. Author Correction: Tetrahydroberberrubine retards heart aging in mice by promoting PHB2-mediated mitophagy. Acta Pharmacol Sin 46, 2073–2074 (2025). https://doi.org/10.1038/s41401-025-01503-z
Published:
Issue date:
DOI: https://doi.org/10.1038/s41401-025-01503-z